Myocardial Infarction clinical trials
The registry lists 2,270 studies for Myocardial Infarction across more than 10 countries. 371 are recruiting or about to start. 1,216 of them are mainly about Myocardial Infarction (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 5 narrower conditions too, such as ST Elevation Myocardial Infarction: 3,329 studies, 670 open.
ClinicalTrials.gov finds 3,914 studies for Myocardial Infarction. How that becomes 2,268 here
This page counts the studies the registry files under Myocardial Infarction, and those it files under no condition that list Myocardial Infarctionthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count
- 3,914Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
- −1,056Filed under a narrower condition, counted on its own pageST Elevation Myocardial Infarction 649 · Shock, Cardiogenic 250 · Non-ST Elevated Myocardial Infarction 107 · Anterior Wall Myocardial Infarction 16 · MINOCA 16
- −275List Myocardial Infarction as a condition, but the registry did not file them under itMost often written as “Acute Myocardial Infarction” (184), “Acute Myocardial Infarction (AMI)” (23), and “Coronary Artery Disease With Myocardial Infarction” (8). The registry filed them under other conditions only, most often Acute Coronary Syndrome (47) and Coronary Artery Disease (38).
- −315Match it another way245 name it in the title, 46 in a keyword, and 24 by a synonym or other text the search reads.
- 2,268The count on this page305 of them list Myocardial Infarction in their own words; the registry filed them under no condition.
Get an email when these change. Save the Myocardial Infarction studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
National Heart, Lung, and Blood Institute (NHLBI) (64) · University of Edinburgh (20) · Mayo Clinic (19) · Assiut University (19) · AstraZeneca (19) · Karolinska Institutet (17) · University College, London (17) · Brigham and Women's Hospital (17)
What is being tested here
Drugs under test in Myocardial Infarction studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Aspirin | 7 | 9 | 28 |
| Dapagliflozin | 5 | 5 | 11 |
| Rivaroxaban | 4 | 4 | 11 |
| Ticagrelor | 3 | 10 | 32 |
| Colchicine | 3 | 5 | 11 |
| Empagliflozin | 2 | 2 | 5 |
| Ferric carboxymaltose | 2 | 0 | 3 |
| Clopidogrel | 1 | 4 | 24 |
| Atorvastatin | 1 | 3 | 13 |
| Prasugrel | 1 | 2 | 9 |
Drug classes tested here NSAIDs 7 open · SGLT2 inhibitors 7 open · P2Y12 inhibitors 4 open · Factor Xa inhibitors 4 open · Beta blockers 3 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Dec 2026The Impact of Fexofenadine Hydrochloride on the Prognosis of Patients Post-Acute Myocardial Infarction · Phase 3 · Second Affiliated Hospital, Zhejiang University, School of Medicine
- Jan 2027ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack · Phase 3 · Novo Nordisk A/S
- Feb 2027Efficacy of Montelukast on STEMl Patients · Phase 3 · Shanghai Zhongshan Hospital
- Jun 2027Dapagliflozin in STEMI · Phase 3 · Ottawa Heart Institute Research Corporation
- Jun 2027Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome · Phase 3 · Assistance Publique - Hôpitaux de Paris
- Jul 2027Selatogrel Outcome Study in Suspected Acute Myocardial Infarction · Phase 3 · Viatris Innovation GmbH
- Sep 2027Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis · Phase 3 · Assistance Publique - Hôpitaux de Paris
- Nov 2026PRE-DETERMINE Cohort Study · Brigham and Women's Hospital
- Nov 2026Voice Analysis Technology to Detect and Manage Depression and Anxiety in Cardiac Rehabilitation · Mayo Clinic
- Nov 2026Calibration Study PREDICT - Prehospital Triage for Suspected Acute Coronary Syndrome Without ST-segment Elevation · Leipzig Heart Science gGmbH
Who these studies take
Of the 255 Myocardial Infarction studies recruiting now, 172 (67%) set no upper age limit and 26 (10%) stop at 75 or younger. 16 (6%) take children under 18. 2 (1%) are for women only and 0 (0%) for men only; 27 (11%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 10 (4%) | 10 (4%) |
| 18 | 199 (78%) | 198 (78%) |
| 30 | 231 (91%) | 229 (90%) |
| 40 | 236 (93%) | 234 (92%) |
| 50 | 243 (95%) | 241 (95%) |
| 65 | 246 (96%) | 245 (96%) |
| 75 | 238 (93%) | 237 (93%) |
| 85 | 198 (78%) | 197 (77%) |
Across all 2,270 studies, recruiting or not: 14% stop at 75 or younger and 4% at 65; 9% take children; 1% are for women only and 3% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Myocardial Infarction studies take
Of 87 phase 4 interventional studies under Myocardial Infarction, half reached primary completion within 42 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 26 mo8–40 · 13 studies | — | — |
| Phase 2 | 27 mo19–42 · 45 studies | — | — |
| Phase 3 | 43 mo30–77 · 57 studies | — | 41 mo24–73 · 33 studies |
| Phase 4 | 42 mo22–78 · 87 studies | — | 42 mo22–78 · 83 studies |
| Interventional, no phase | 34 mo15–57 · 354 studies | 31 mo15–49 · 33 studies | 35 mo14–58 · 321 studies |
| Observational | 48 mo17–114 · 333 studies | 17 mo7–32 · 37 studies | 54 mo19–140 · 296 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 13, 2026.
Started recruiting5
- A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular DiseaseNov 10, 2026NCT07839936
- Telegram Messenger Support for Smoking Cessation After Heart AttackNov 9, 2026NCT07230249
- Breisgau PHENO-HEART MIOct 27, 2026NCT06166407
- Optimal Timing of Staged Complete Revascularization in STEMI With Multivessel Disease (OPTION-STEMI2)Oct 23, 2026NCT07741721
- Estimation of Cardiovascular Risk in Patients With Crohn's Disease and Ulcerative Colitis (PROVACI)Oct 16, 2026NCT07095634
Newly registered8
- To Evaluate The Efficacy And Safety Of Rivaroxaban In Combination With Aspirin Compared With Aspirin Monotherapy In Patients With Stable Coronary Artery Disease (CAD) and High Ischemic RiskNov 10, 2026NCT07928583
- Determination of Specificity and Sensitivity in Detecting Myocardial Infarction Using the EDE CARDIO BIO-MAP MachineNov 9, 2026NCT07926230
- Heart@Home Safety and Efficacy of Hospital-at-Home Care Versus Standard Hospitalization in Cardiac PatientsNov 3, 2026NCT07913152
- Evaluating SGLT2 Inhibitors for the Reduction of No-Reflow Phenomenon in Patients Undergoing PCIOct 27, 2026NCT07898709
- Pilot Study to Determine the Optimal Protocol for Preoperative Transcutaneous Vagal NeurostimulationOct 23, 2026NCT07891390
Show 3 moreShow fewer
- AI-ECG Detection of Occlusion Myocardial Infarction at Emergency Department Triage (TRIACS)Oct 20, 2026NCT07882849
- Multimodality Assessment of Myocardial Reperfusion After Primary Percutaneous Coronary InterventionOct 15, 2026NCT07876791
- TOP-CABG Trial: Follow-up Extension (TOP-CABG FE)Oct 13, 2026NCT07871591
Studies
Recruiting first, then most recently updated. Showing 50 of 2,270. Browse all 2,270 → or search them.
- To Evaluate The Efficacy And Safety Of Rivaroxaban In Combination With Aspirin Compared With Aspirin Monotherapy In Patients With Stable Coronary Artery Disease (CAD) and High Ischemic RiskNot yet recruitingNCT07928583Not applicable
- A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular DiseaseRecruitingNCT07839936Phase 21 country
- Determination of Specificity and Sensitivity in Detecting Myocardial Infarction Using the EDE CARDIO BIO-MAP MachineNot yet recruitingNCT07926230
- ODSSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Cardiac Death in Moderated LVEF in ischEmic cardiomyopathYRecruitingNCT07545512Not applicable1 country
- Telegram Messenger Support for Smoking Cessation After Heart AttackRecruitingNCT07230249Not applicable1 country
- The Application of T1 Mapping in Real-WorldRecruitingNCT073546461 country
- The DANE-HEART Trial - Computed Tomography Coronary Angiography for Primary PreventionEnrolling by invitationNCT05677386Not applicable1 country
- Elicit Drugs in Myocardial InfarctionNot yet recruitingNCT07919925
- Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial InfarctionRecruitingNCT07362446Phase 21 country
- Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) StudyRecruitingNCT049733974 countries
- Heart@Home Safety and Efficacy of Hospital-at-Home Care Versus Standard Hospitalization in Cardiac PatientsRecruitingNCT07913152Not applicable1 country
- Evaluating SGLT2 Inhibitors for the Reduction of No-Reflow Phenomenon in Patients Undergoing PCINot yet recruitingNCT07898709Phase 21 country
- Selatogrel Outcome Study in Suspected Acute Myocardial InfarctionEnrolling by invitationNCT04957719Phase 347 countries
- Breisgau PHENO-HEART MIRecruitingNCT061664071 country
- Mechanisms of Myocardial Injury and Ischemia in Patients With Rapid Atrial FibrillationRecruitingNCT069511001 country
- Cilostazol for Prevention of Recurrent Stroke TrialNot yet recruitingNCT07174414Phase 31 country
- Optimal Timing of Staged Complete Revascularization in STEMI With Multivessel Disease (OPTION-STEMI2)RecruitingNCT07741721Not applicable1 country
- Pilot Study to Determine the Optimal Protocol for Preoperative Transcutaneous Vagal NeurostimulationNot yet recruitingNCT07891390Not applicable1 country
- iLITE, Clinical Performance of the Angiolite™ Drug-Eluting StentNot yet recruitingNCT07887230
- NeuroAiD Patient-Reported Outcomes in Patients With Mild to Moderate Ischemic StrokeRecruitingNCT07828210Phase 41 country
- AI-ECG Detection of Occlusion Myocardial Infarction at Emergency Department Triage (TRIACS)Not yet recruitingNCT078828491 country
- Estimation of Cardiovascular Risk in Patients With Crohn's Disease and Ulcerative Colitis (PROVACI)RecruitingNCT070956341 country
- Cardiovascular Risk in Patients With IBDNot yet recruitingNCT07663201
- Multimodality Assessment of Myocardial Reperfusion After Primary Percutaneous Coronary InterventionNot yet recruitingNCT07876791
- Clinical Investigation of the Cardioprotective Effect of Early Administration of SGLT2 in Patients Presented With AMIRecruitingNCT06009874Not applicable1 country
- STunning in Acute Myocardial Infarction - BASRecruitingNCT06562582Phase 41 country
- Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)RecruitingNCT06569121Not applicable1 country
- Analysis of Life-threatening ARrhythMias After Acute Coronary SyndromeRecruitingNCT078240501 country
- TOP-CABG Trial: Follow-up Extension (TOP-CABG FE)Not yet recruitingNCT07871591
- Effectiveness of Digital Cardiac Rehabilitation on Functional Capacity in Patients With Myocardial InfarctionRecruitingNCT07867197Not applicable1 country
- AI-based Decision Support in Acute Chest PainNot yet recruitingNCT07864038Not applicable
- Evaluation of a Remote Behavioural Stress Recovery Intervention for Myocardial Infarction Patients Younger Than Fifty-five (BRIM-55): A Feasibility StudyRecruitingNCT07706816Not applicable1 country
- NMR Metabolomics-Based Risk Assessment and Stratified Digital Health Interventions in Middle-Aged Adults (PREMAP)RecruitingNCT07820800Not applicable1 country
- Barts Revascularisation RegistryRecruitingNCT052557051 country
- DAN-RELEASE - Reconsidering Long-Term Aspirin in the Elderly Patients With Stable Ischemic Heart DiseaseRecruitingNCT07795398Phase 41 country
- Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular RiskRecruitingNCT04774159Phase 310 countries
- High-Sensitivity Troponin T Kinetics and 30-Day Outcomes After Major Abdominal Surgery (TROP-MAS)Not yet recruitingNCT078504921 country
- Trends and Risk Factors of Adverse Cardiovascular and Cerebrovascular Events After Primary PCIRecruitingNCT078339951 country
- Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction PatientsRecruitingNCT05604131Phase 21 country
- Germany on Target RegistryNot yet recruitingNCT07835282
- TMS for Sympathetic Hyperactivity and Inflammation in Acute Myocardial InfarctionRecruitingNCT07842770Not applicable1 country
- Enhancing Cardiac Rehabilitation Attendance After Secondary Myocardial Infarction Through Clinician Messaging and Motivational CallsRecruitingNCT07485491Not applicable1 country
- CHIP in Health and DiseaseNot yet recruitingNCT077805521 country
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)RecruitingNCT05485961Phase 2/335 countries
- A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)RecruitingNCT07428473Phase 12 countries
- Impact of Pre-Hospital and Hospital Delays on Myocardial Infarction OutcomesRecruitingNCT067384981 country
- Beyond the Mehran Risk Score: Predictive Value of Total Ischemic Time for Contrast-Induced Nephropathy in ST Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.Not yet recruitingNCT07826572
- Implementation of IVS3 for Upper Limb Motor RecoveryRecruitingNCT06483230Not applicable1 country
- Non-invasive Coronary Thrombus Imaging to Define These Cause of Acute Myocardial InfarctionRecruitingNCT061135101 country
- First-in-Human Study Using the SiroMax™ Sirolimus-Coated Balloon Catheter as a Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter to Treat Subjects Who Have Coronary Artery Disease (CAD) Involving In-Stent Restenosis (ISR) or an Unstented Lesion in a Small Coronary Vessel (DNSV).RecruitingNCT07811024Not applicable1 country